相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulating the response to targeted MEK inhibition in melanoma Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation
William H. Conrad et al.
CELL CYCLE (2012)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells
Tomonori Yaguchi et al.
JOURNAL OF IMMUNOLOGY (2012)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V. Long et al.
LANCET ONCOLOGY (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAFV600E in Human Melanoma
Travis L. Biechele et al.
SCIENCE SIGNALING (2012)
Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors
Hubing Shi et al.
CANCER DISCOVERY (2012)
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
William E. Damsky et al.
CANCER CELL (2011)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Dermoscopical and Histopathological Patterns of Nevi Correlate with the Frequency of BRAF Mutations
Iris Zalaudek et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
A Re-evaluation of the Oncogenic Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
Olivia M. Lucero et al.
CURRENT ONCOLOGY REPORTS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
Bonnie E. Gould Rothberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Wnt Survival Guide: From Flies to Human Disease
Andy J. Chien et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
Andy J. Chien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
BRAF and NRAS mutations in melanoma and melanocytic nevi
Jenny N. Poynter et al.
MELANOMA RESEARCH (2006)
Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma
IM Bachmann et al.
CLINICAL CANCER RESEARCH (2005)
Analysis of BRAF mutation in primary and metastatic melanoma
M Libra et al.
CELL CYCLE (2005)
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma
MB Lens et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
BRAF kinase gene V599E mutation in growing melanocytic lesions
R Loewe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Mutations of the BRAF gene in benign and malignant melanocytic lesions
AS Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Loss of β-catenin expression associated with disease progression in malignant melanoma
T Kageshita et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
